Page 135

Karger_ESC London_2013

London, United Kingdom 2013 Clinicians‘ choices with increasing burden of stroke Chair: G. Ford, UK Growing burden of stroke C. Wolfe, UK Clinical decisions and therapeutic choices in AIS H. Audebert Germany On hope and expectations: how ongoing trials may optimize management of AIS G. Albers, USA Industry sponsored lunch symposium by Lundbeck Cerebrovasc Dis 2013; 35 (suppl 3)1-854 135 12:45-14:15 Room 7,8,11,12 Lunch Satellite Symposium Boehringer Ingelheim Working together to improve stroke prevention in patients with atrial fibrillati-on Chairs: J. Camm, UK and S. Davis, Australia Welcome and introduction J. Camm, UK Diagnosing AF in high risk patients – innovative tools and clinical results T. Sanna, Italy Safeguarding the brain – protecting against the devastating effects of ischaemic stroke H.–C. Diener, Germany Knowledge is our best defense – consensus on management of acute emergency situations in stroke patients treated with novel oral anticoagulants T. Steiner, Germany Shielding patients from stroke – how can cardiologists and neurologists improve outcomes in patients with AF? Panel discussion moderated by S. Davis, Australia Industry sponsored lunch symposium by Boehringer Ingelheim 12:45-14:15 Room 14,15,16 Lunch Satellite Symposium Lundbeck


Karger_ESC London_2013
To see the actual publication please follow the link above